Relation between leukocyte telomere length and incident coronary heart disease events (from the 1995 Canadian Nova Scotia Health Survey)

Siqin Ye, Jonathan A. Shaffer, Min Suk Kang, Manjunath Harlapur, Paul Muntner, Elissa Epel, Duane Guernsey, Joseph E. Schwartz, Karina W. Davidson, Susan Kirkland, Lawrence S. Honig, Daichi Shimbo

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

28 Citas (Scopus)

Resumen

Leukocyte telomere length has been proposed as a biomarker of cellular aging and atherosclerosis. The aim of this study was to determine whether leukocyte telomere length is independently associated with incident coronary heart disease (CHD) in the general population. Telomere length was measured using a polymerase chain reaction method for participants enrolled in the 1995 Nova Scotia Health Survey (NSHS95; n = 1,917). The primary end point was the first occurrence of a fatal or nonfatal CHD event. During a mean follow-up period of 8.7 years, 164 fatal or nonfatal CHD events occurred. Compared with participants in the longest tertile of telomere length, those in the middle and shortest tertiles had increased incidence of CHD events (6.2, 11.2, and 12.2 per 1,000 person-years, respectively). After adjustment for demographics, traditional risk factors, and inflammatory markers including high-sensitivity C-reactive protein, interleukin-6, and soluble intercellular adhesion molecule-1, those in the middle tertile had significantly elevated risk for incident CHD (hazard ratio 1.63, 95% confidence interval 1.07 to 2.51, p = 0.02) compared with the longest tertile, whereas the risk for those in the shortest tertile was nonsignificantly elevated (hazard ratio 1.25, 95% confidence interval 0.82 to 1.90, p = 0.30). In conclusion, these findings do not support a linear association between leukocyte telomere length and incident CHD risk in the general population.

Idioma originalEnglish
Páginas (desde-hasta)962-967
Número de páginas6
PublicaciónAmerican Journal of Cardiology
Volumen111
N.º7
DOI
EstadoPublished - abr. 1 2013

Nota bibliográfica

Funding Information:
This study was supported by Grants HL-091099 and HL-084034 from the National Heart, Lung, and Blood Institute , Bethesda, Maryland; National Health and Welfare of Canada , Ottawa, Ontario, Canada; the Nova Scotia Department of Health , Halifax, Nova Scotia, Canada; and the Heart and Stroke Foundation of New Brunswick , St. John, New Brunswick, Canada. Dr. Ye is supported by an American College of Cardiology/Merck Foundation Fellowship Award and by Grant T32HL007854-16 from the National Institutes of Health , Bethesda, Maryland. Dr. Honig also receives support from the Alzheimer's Association , Chicago, Illinois; the Alzheimer's Disease Drug Discovery Foundation , New York, New York; Grant P50AG008702 from the National Institute on Aging , Bethesda, Maryland; the Henry Panasci Fund ; and the Taub Institute , New York, New York.

ASJC Scopus Subject Areas

  • Cardiology and Cardiovascular Medicine

PubMed: MeSH publication types

  • Comparative Study
  • Journal Article
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

Huella

Profundice en los temas de investigación de 'Relation between leukocyte telomere length and incident coronary heart disease events (from the 1995 Canadian Nova Scotia Health Survey)'. En conjunto forman una huella única.

Citar esto